The TJX Companies, a prominent off-price apparel and lifestyle retail company, has named Charles Wagner, Jr. to its board of directors with immediate effect.
Charles Wagner, Jr. currently holds the position of Executive Vice President and Chief Financial Officer at Vertex Pharmaceuticals, Inc., a role he has held since 2019. He is responsible for overseeing various crucial functions at Vertex, including accounting, finance, internal audit, investor relations, business development, and global security and facilities.
Previously, from 2015 to 2019, Charles Wagner, Jr. served as Executive Vice President of Finance and CFO at Ortho Clinical Diagnostics. Prior to this, he held senior financial roles across diverse industries, including life sciences.
Carol Meyrowitz, Executive Chairman of the Board at The TJX Companies, expressed her enthusiasm about Charles Wagner’s appointment, stating, «We are delighted to welcome Charlie as the newest member of our board of directors. With over a decade of experience in public and private company CFO roles and extensive corporate finance expertise, he brings a fresh perspective to our board.»
Meyrowitz added, «Charlie’s deep financial knowledge complements the diverse experience of our existing Directors, which is crucial for overseeing our complex global business. We look forward to collaborating with Charlie as we continue to focus on both short-term and long-term growth opportunities for our company.»
In February of this year, TJX predicted a strong increase in annual sales for 2023. The company anticipated higher sales due to inflation driving cost-conscious yet quality-conscious consumers toward off-price retailers, where they can discover appealing deals and promotions.
